Loading market data...
Latest Top News
Show more
Glenmark Pharma Receives US FDA Approval For Progesterone Vaginal Inserts
Glenmark Pharmaceuticals Ltd has received US FDA approval for its Progesterone Vaginal Inserts, 100 mg. This approval strengthens Glenmark’s portfolio in women’s health, enabling the company to expand its presence in the US market and support therapeutic needs in reproductive medicine.
Stay Ahead – Explore Now! Crypto Markets Heat Up: Bullish Exchange Launches Trump Token Futures as CoinDesk Expands Benchmarks






